Read More Pharma Industry News Charles River Laboratories to acquire gene therapy CDMO Vigene Biosciences Charles River Laboratories International has signed an all-cash deal worth $292.5 million to acquire Vigene Biosciences, a US-based… bySrinathMay 19, 2021
